Hematopoietic lineage-converted T cells carrying tumor-associated antigen-recognizing TCRs effectively kill tumor cells

Tumor-associated antigen (TAA) T-cell receptor (TCR) gene-engineered T cells exhibit great potential in antitumor immunotherapy. Considering the high costs and low availability of patient-derived peripheral blood T cells, substantial efforts have been made to explore alternatives to natural T cells....

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Immunother Cancer
Glavni autori: Hu, Fangxiao, Huang, Dehao, Luo, Yuxuan, Zhou, Peiqing, Lv, Cui, Wang, Kaitao, Weng, Qitong, Liu, Xiaofei, Guan, Yuxian, Geng, Yang, Du, Juan, Chen, Jiekai, Wang, Jinyong, Wu, Hongling
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2020
Teme:
Short Report
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7368548/
https://ncbi.nlm.nih.gov/pubmed/32669292
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2019-000498
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items